Bipolar Disorder Depression
9
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Time Restricted Eating (TRE) in Bipolar Disorder
Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults
HD-tDCS for Adolescent Bipolar Depression Targeting S1
Scopolamine in Bipolar Depression
Cognitive Effects Associated With Hippocampal Neurogenesis Induced by ECT in the Treatment of Depression
AI-based Multi-center Research on Identification/Classification/Aided Diagnosis of Mood Disorder
Candesartan as an Adjunctive Treatment for Bipolar Depression
Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar Depression
Minocycline and Aspirin in the Treatment of Bipolar Depression